The DOI matches its Crossref record; 27 of the 32 references it cites were found in a registry or an index.
Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance.
Open accessPublished version of a preprint
Abstract
Background Overdose deaths from synthetic opioids (e.g., fentanyl) increased 10-fold in the United States from 2013 to 2018, despite such opioids being rare in illicit drug markets west of the Mississippi River. Public health professionals have feared a “fentanyl breakthrough” in western U.S. drug markets could further accelerate overdose mortality. We evaluated the number and nature of western U.S. fentanyl deaths using the most recent data available. Methods We systematically searched jurisdictions west of the Mississippi River for publicly available data on fentanyl-related deaths since 2018, the most recent Centers for Disease Control and Prevention (CDC) statistics. Using mortality data from 2019 and 2020, we identified changes in fentanyl-related mortality rate and proportion of fatal heroin-, stimulant, and prescription pill overdoses involving fentanyl. Results Seven jurisdictions had publicly available fentanyl death data through December 2019 or later: Arizona; California; Denver County, CO; Harris County, TX; King County, WA; Los Angeles County, CA; and Dallas-Fort Worth, TX (Denton, Johnson, Parker, and Tarrant counties). All reported increased fentanyl deaths over the study period. Their collective contribution to national synthetic narcotics mortality increased 371 % from 2017 to 2019. Available 2020 data shows a 63 % growth in fentanyl-mortality over 2019. Fentanyl-involvement in heroin, stimulant, and prescription pill deaths has substantially grown. Discussion Fentanyl has spread westward, increasing deaths in the short-term and threatening to dramatically worsen the nation’s already severe opioid epidemic in the long-term. Increasing the standard dose of naloxone, expanding Medicaid, improving coverage of addiction treatment, and public health educational campaigns should be prioritized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, fentanyl did not saturate each state’s unregulated drug market at the same time25; from about 2013 onward, it spread from east to west over the course of several years.20,26”
From Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon (2024) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
Wilson, N., Kariisa, M., Seth, P., Smith, H., & Davis, N. L. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6911a4 · Cited by 1,123
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
Self-citationUnderstanding Links among Opioid Use, Overdose, and Suicide
Bohnert, A. S. B., & Ilgen, M. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1802148 · Cited by 333
Addressing the Fentanyl Threat to Public Health
Frank, R. G., & Pollack, H. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1615145 · Cited by 242
Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
Tori, M. E., Larochelle, M. R., & Naimi, T. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2361 · Cited by 195
Our other prescription drug problem
Lembke, A., Papac, J., & Humphreys, K. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1715050 · Cited by 160
Self-citationFentanyl shock: The changing geography of overdose in the United States
Zoorob, M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.010 · Cited by 160
Hoots, B., Vivolo-Kantor, A. M., & Seth, P. (2020) · Addiction · doi:10.1111/add.14878 · Cited by 150
Research works printed but not linked: 1
- Greenson, 2020, Third Wave: fentanyl washed into Humboldt County in 2019 with deadly consequences, North Coast J.
Cited by
Sorted by citations
Items 101–161 of 161
Liu, S., Casillas, S. M., Ussery, E. N., Sheppard, M., & Vivolo-Kantor, A. M. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112886 · Cited by 7
Child Protection System Interactions for Children With Positive Urine Screens for Illicit Drugs
Rebbe, R., Malicki, D. M., Siddiqi, N., Huang, J. S., Putnam‐Hornstein, E., & Laub, N. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3133 · Cited by 8
Epidemiology of Opioid Use, Misuse, and Overdoses
Draghmeh, K., Gold, M. S., & Fuehrlein, B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00649-4 · Cited by 6
Heat exposure and drug overdose mortality in the USA
Dennett, J. M., Carrión, D., Fiellin, D. A., & Gonsalves, G. (2025) · Addiction · doi:10.1111/add.70191 · Cited by 6
Maclean, J. C., Hulser, S., Stein, B. D., & Saloner, B. K. (2025) · Health Affairs · doi:10.1377/hlthaff.2024.01289 · Cited by 6
Perceptions of fentanyl among African Americans who misuse opioids: implications for risk reduction
Rigg, K. K., & Kusiak, E. S. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00915-6 · Cited by 6
US overdose mortality saw first drop below the Jalal-Burke exponential growth curve in 2024
Friedman, J. R., Palamar, J. J., Ciccarone, D., Gaines, T. L., Bórquez, A., Shover, C. L., & Strathdee, S. A. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105320 · Cited by 5
Self-citationAllen, S. M., Nichols, T. A., Fawcett, J., & Lin, S. (2022) · American Journal on Addictions · doi:10.1111/ajad.13267 · Cited by 5
Stimulant use among patients in opioid treatment settings: Provider perspectives
Breland, H., Larkins, S., Antonini, V. P., Freese, T. E., McGovern, M. P., Dunn, J. A., & Rawson, R. A. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209012 · Cited by 5
Palau, C. B., Akikuni, M., Latsky-Campbell, B., & Wagner, J. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2267110 · Cited by 5
Daniulaityte, R., Ruhter, L., & Katz, C. M. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2284341 · Cited by 5
Frequency of Fentanyl Exposure in Emergency Department Patients With Illicit Drug Use
Sacco, D. L., Probst, M. A., Mannes, Z. L., Comer, S. D., Martins, S. S., & Chang, B. (2024) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2024.10.016 · Cited by 5
Naloxone-initiated mechanochemical synthesis of poly(lactic acid)
Ebqa’ai, M., Dias, S. B. K., Kassick, A. J., Averick, S. E., & Nelson, T. L. (2024) · RSC Mechanochemistry · doi:10.1039/d4mr00046c · Cited by 4
Leonhardt, M. M., Spartz, J. R., Shankar, A., & Murphy, S. A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1117841 · Cited by 5
Unveiling the Physiological Systemic Consequences of Adolescent Opioid Use: A Systematic Review
Folorunsho, A. A., Oyovwi, M. O., Akano, O. P., Okeleji, L. O., Adedeji, B. O., & Oluwatoyin, A. L. (2025) · Journal of Child & Adolescent Substance Use · doi:10.1080/29973368.2025.2546438 · Cited by 3
It is time to recognize that synthetic opioids are not going away
Bohnert, A. S. B., & Lin, L. A. (2021) · Addiction · doi:10.1111/add.15376 · Cited by 3
Addressing fentanyl‐related harms: maximizing the efficiency of innovative interventions
May, T., Buhociu, M., & Holloway, K. R. (2020) · Addiction · doi:10.1111/add.15323 · Cited by 3
Choi, N. G., Choi, B. Y., DiNitto, D. M., Marti, C. N., & Baker, D. (2022) · Clinical Toxicology · doi:10.1080/15563650.2021.2016798 · Cited by 3
The Evolving Overdose Crisis: United States Needs Robust Policy Change to Address the Fourth Wave
Aronowitz, S. V., & Reed, M. K. (2025) · American Journal of Public Health · doi:10.2105/ajph.2025.308041 · Cited by 3
Godvin, M., Friedman, J. R., Molina, C. A., Koncsol, A. J., Romero, R., Juurlink, D. N., & Shover, C. L. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113224 · Cited by 2
Self-citationTyagi, S., Singh, J. P., Manzoor, A., Basra, S., Sharma, Y., Sharma, P., Shubham, S., Kaur, A., & Kaur, S. (2025) · Cureus · doi:10.7759/cureus.99586 · Cited by 2
Janssen, T., Garner, B. R., Yermash, J., Yap, K. R., & Becker, S. J. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00409-7 · Cited by 2
Ondocsin, J., Moran, L., Ciccarone, D., Outram, S. M., Werb, D., Holm, N., & Arnold, E. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321574 · Cited by 2
Polysubstance use and lived experience: new insights into what is needed
Shover, C. L., Spoliansky, J., & Godvin, M. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000876 · Cited by 2
Self-citationGeographic Trends in Opioid and Polysubstance Overdose Deaths in the US, 2014–2023
Oles, W. C., Liu, M., Wakeman, S. E., & Larochelle, M. R. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09589-1 · Cited by 2
Kiang, M. V., & Alexander, M. J. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae156 · Cited by 2
Harruff, R. C., Barbour, W. L., & Yarid, N. A. (2024) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15526 · Cited by 1
Vivares, S., Abbara, C., Jousset, N., Ferec, S., Malbranque, S., Briet, M. B., & Drevin, G. (2025) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2025.103021 · Cited by 1
Halifax, J. C., Lim, L., Ahern, J., Steiger, S., Shapiro, B. J., & Lynch, K. L. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113185 · Cited by 1
Wang, P., & Ma, G. (2024) · Medicine · doi:10.1097/md.0000000000038049 · Cited by 1
Allen, B., & Harocopos, A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341062 · Cited by 1
Alhassan, F., Karami, H., Cheng, E. K.-W., Lee, S., Fung, I. C., Bohler, R. M., & Chowell, G. (2026) · Annals of Epidemiology · doi:10.1016/j.annepidem.2026.110055 · Cited by 1
Fentanyl use among people who inject drugs in two large Pacific Northwest metropolitan areas
Lipira, L. E., Glick, S. N., Moreno, C., Sevillano, L., Town, M., & Menza, T. W. (2026) · Harm Reduction Journal · doi:10.1186/s12954-025-01384-9 · Cited by 1
Suh, L., Ko, E., Baek, B., Yoo, J. W., Lee, S. W., Shen, J. J., Lee, S. R., & Kang, M. (2026) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-026-02960-w · Cited by 1
A perfect calming: Exploring the etiology of declining US overdose deaths
Ciccarone, D., Ondocsin, J., & Post, L. A. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105309 · Cited by 1
Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions
Hartung, D. M., Geddes, J., Hallvik, S. E., Korthuis, P. T., Middleton, L., Leichtling, G. J., Hildebran, C., & Kim, H. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07477-6 · Cited by 1
A New Wave of the Overdose Epidemic arises during the COVID-19 Pandemic
Suvar, T., Buvanendran, A., Music, S. C., & Compton, W. M. (2023) · Advances in Clinical Medical Research and Healthcare Delivery · doi:10.53785/2769-2779.1127 · Cited by 1
Naloxone Distribution in Texas 2018-2022: A State-Wide Program for Opioid Overdose PreventionPreprint
Irwin, K. S., Mathias, C. W., Wang, Z., Emmerich, A. L., & Cleveland, L. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3483277/v1
Behavioral economic strategies to increase naloxone acquisition and carryingPreprint
Feuerstein-Simon, R., Dolan, A. R., Sharma, M., Lowenstein, M., Buttenheim, A. M., Meisel, Z. F., & Cannuscio, C. C. (2024) · medRxiv · doi:10.1101/2024.01.18.23296155
Opioid Use and Overdose Patterns in Puerto Rico in 2020-2022: A Retrospective Descriptive Study
Burgos-Barreto, G. (2024) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v7-i1-43
Ramalingam, N., Rieke, E., McDonnell, M. M., Myers, E., & Hoover, D. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00485-3
Austin, E. J., Briggs, E. S., Corcorran, M. A., Chen, J. A., Cotta, N., Behrends, C. N., Prohaska, S. M., LaKosky, P. A., Kapadia, S. N., Perlman, D. C., et al. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2024.2447411
Rana, D. B., DeBaer, L., & Pourcyrous, M. (2025) · American Journal of Perinatology · doi:10.1055/a-2624-3880
Goh, B. Y., Williams, E. C., Wettemann, C., Fockele, C. E., Frohe, T. M., Williams, G., Holland, N., Rourke, R., Pitcher, R., Oliphant-Wells, T., et al. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209747
Hartung, D. M., Geddes, J., Hallvik, S. E., Korthuis, P. T., Middleton, L., Leichtling, G. J., Hildebran, C., & Kim, H. (2022) · Figshare · doi:10.6084/m9.figshare.18461940
Additional file 2 of Testing the test strips: laboratory performance of fentanyl test strips
Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.25026006
Shin, S. S., LaForge, K., Stack, E., Pope, J., Leichtling, G. J., Larsen, J. E., Leahy, J. M., Seaman, A., Hoover, D. B., Chisholm, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20291013
Cook, R. R., Foot, C. A., Arah, O. A., Humphreys, K., Rudolph, K. E., Luo, S. X., Tsui, J. I., Levander, X. A., & Korthuis, P. T. (2023) · Figshare · doi:10.6084/m9.figshare.22607152
Self-citationAdditional file 3 of Testing the test strips: laboratory performance of fentanyl test strips
Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.26669133
Additional file 1 of Testing the test strips: laboratory performance of fentanyl test strips
Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024) · Figshare · doi:10.6084/m9.figshare.25025887
Janssen, T., Garner, B. R., Yermash, J., Yap, K. R., & Becker, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26617246
Buckley, C. M., Ye, Y., Kerr, W. C., Mulia, N., Puka, K., Rehm, J. T., & Probst, C. (2022) · Figshare · doi:10.6084/m9.figshare.21393885
Stability or versatility: transitions in fentanyl routes of administration
Ondocsin, J., Mars, S. G., Holm, N., Schlosser, A. V., Fessel, J. N., Cowan, A., Duke, M. R., & Ciccarone, D. (2025) · Harm Reduction Journal · doi:10.1186/s12954-025-01373-y
Balakrishnan, H., Campalans, N., Marambage, K., REISCH, J. S., & Nijhawan, A. E. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12387-z
Schneider, K. E., Allen, S. T., O’Rourke, A., Reid, M. C., Conrad, M. A., Garrett, B. A., Hautala, D. S., Lewis, K., Lewis, S., Wilson, L., et al. (2026) · Harm Reduction Journal · doi:10.1186/s12954-025-01303-y
Ramos, L. M. L., Durán, J. I. S., & Barrero, M. S. R. (2025) · Academia & Derecho · doi:10.18041/2215-8944/academia.30.12975
Eger, W. H., Bazzi, A. R., Crable, E. L., Abramovitz, D. A., Vera, A., Vera, C. F., Rangel, G., Friedman, J. R., Pitpitan, E. V., Patterson, T. L., et al. (2026) · medRxiv · doi:10.64898/2026.05.27.26354253
Prevalence of p -fluorofentanyl and xylazine in postmortem fentanyl casework
Ballotari, M., Truver, M. T., Hoyer, J. L., Goldberger, B. A., & Chronister, C. W. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag035
Did Drug Decriminalization Increase Overdoses
Hall, D., Hansen, B., & Matsuzawa, K. (2026) · National Bureau of Economic Research · doi:10.3386/w35427
A novel community mobilization framework to scale youth opioid prevention education in Texas
Peña-Purcell, N. C., & Ory, M. G. (2026) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2026.103599
Trends in Arrhythmia-Related Mortality Associated With Congenital Heart Disease in the United States
Chenyue, Z., Liu, R., Liu, J., Ning, P., Peng, L., Gao, Y., Ji, Z., & Pan, S. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103121
Metadata
- Authors
- Shover, C. L., Falasinnu, T. O., Dwyer, C. L., Santos, N. B., Cunningham, N. J., Freedman, R. B., Vest, N. A., & Humphreys, K.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- University of California, Los Angeles (US)
- Los Angeles LGBT Center (US)
- Brown University (US)
- Corresponding author
- Shover, Chelsea L.
- ORCID
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 216
- Pages
- 108314
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC7521591
- OpenAlex
- W3090555497
- Semantic Scholar
- 14ab5e310f56292fe3ca12fc9baea747bfd402e5
- Cited by
- 162
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 24 · 2023: 31 · 2022: 36 · 2021: 32 · 2020: 3
- FWCI
- 19.09
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Wu Tsai Neurosciences Institute, Stanford University
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- fentanyl, opioid overdose deaths, synthetic opioids, opioid epidemic, American West, heroin overdose, stimulant overdose, naloxone, access to addiction treatment, Medicaid expansion, public health education
- MeSH terms
- Analgesics, Opioid, Heroin, Female, Fentanyl, Humans, Longitudinal Studies, Male, Local Government, Opioid-Related Disorders, Population Surveillance, State Government, Illicit Drugs, United States, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review